124 related articles for article (PubMed ID: 3561600)
1. Nitroblue tetrazolium test in patients with Hodgkin's disease in the course of chemotherapy.
Kemona H; Wysocka J; Prokopowicz J; Kiluk S
Neoplasma; 1987; 34(1):107-13. PubMed ID: 3561600
[TBL] [Abstract][Full Text] [Related]
2. Plasma and leukocytic bactericidal activity in the course of chemotherapy of Hodgkin's disease.
Wysocka J; Kemona H; Prokopowicz J; Kiluk S
Acta Med Pol; 1987; 28(1-4):99-107. PubMed ID: 3506375
[No Abstract] [Full Text] [Related]
3. [Experience with the management of patients with therapy-resistant Hodgkin's disease].
Berényi E; Szegedi G
Orv Hetil; 1984 Nov; 125(45):2737-40, 2743. PubMed ID: 6548560
[No Abstract] [Full Text] [Related]
4. [Results with MOPP combination chemotherapy in Hodgkin's disease (author's transl)].
Neumann E
Wien Klin Wochenschr; 1981 Feb; 93(4):134-7. PubMed ID: 6895134
[TBL] [Abstract][Full Text] [Related]
5. [Clinical and hematological characteristics and MOPP tolerance of patients with Hodgkin's lymphoma in the bone marrow].
Fiacchini M; Lauria F; Mazza P; Tura S
Haematologica; 1982 Jun; 67(3):394-401. PubMed ID: 6814996
[No Abstract] [Full Text] [Related]
6. [Results of combined chemotherapy (MOPP) in the treatment of patients with generalized Hodgkin's disease].
Aghai E; Kende G; Many A; Ramot B
Harefuah; 1974 Apr; 86(7):348-51. PubMed ID: 4846045
[No Abstract] [Full Text] [Related]
7. Combined modality therapy in previously untreated patients with advanced Hodgkin's disease: A 24-year follow-up study.
Salloum E; Doria R; Farber LR; Roberts KB; Cooper DL
Cancer J Sci Am; 1995; 1(4):267-73. PubMed ID: 9166487
[TBL] [Abstract][Full Text] [Related]
8. Doxorubicin, bleomycin, vinblastine, and dacarbazine (ABVD) salvage of mechlorethamine, vincristine, prednisone, and procarbazine (MOPP)-resistant advanced Hodgkin's disease.
Piga A; Ambrosetti A; Todeschini G; Cetto G; Perona G; Cellerino R
Cancer Treat Rep; 1984; 68(7-8):947-51. PubMed ID: 6204754
[TBL] [Abstract][Full Text] [Related]
9. [Successful chemotherapy of cancer. Remission of Hodgkin's disease. IV].
Lopez M
Clin Ter; 2001; 152(3):203-6. PubMed ID: 11692542
[No Abstract] [Full Text] [Related]
10. [Feasibility study of application of international prognostic score on prediction of prognosis for advanced Hodgkin's lymphoma].
Fu XH; Wang SS; Huang Y; Wang B; Huang HQ; Zhang L; Sun XF; Xu RH; Lin TY
Ai Zheng; 2006 Aug; 25(8):1013-8. PubMed ID: 16965685
[TBL] [Abstract][Full Text] [Related]
11. [Treatment of advanced Hodgkin's disease: an analysis of 128 cases].
Zhou L; Wang Q; Feng F
Zhonghua Zhong Liu Za Zhi; 2000 Jul; 22(4):333-5. PubMed ID: 11778565
[TBL] [Abstract][Full Text] [Related]
12. Combination chemotherapy in the treatment of advanced Hodgkin's disease.
Borromeo VD; Wilner FR; Axelrod AR; Schneider JR
Mich Med; 1975 Sep; 74(27):557-63. PubMed ID: 1160622
[No Abstract] [Full Text] [Related]
13. Chemotherapy strategies to improve the control of Hodgkin's disease: the Richard and Hinda Rosenthal Foundation Award Lecture.
Bonadonna G
Cancer Res; 1982 Nov; 42(11):4309-20. PubMed ID: 6181867
[TBL] [Abstract][Full Text] [Related]
14. Pediatric Hodgkin's disease.
Oliapuram Jose B; Koerner P; Bertolone S; Patel CC; Spanos WJ; Paris KJ; Silverman CL; Yashar CM
J Ky Med Assoc; 2004 Mar; 102(3):104-6. PubMed ID: 15067795
[TBL] [Abstract][Full Text] [Related]
15. Secondary amenorrhea after Hodgkin's lymphoma is influenced by age at treatment, stage of disease, chemotherapy regimen, and the use of oral contraceptives during therapy: a report from the German Hodgkin's Lymphoma Study Group.
Behringer K; Breuer K; Reineke T; May M; Nogova L; Klimm B; Schmitz T; Wildt L; Diehl V; Engert A;
J Clin Oncol; 2005 Oct; 23(30):7555-64. PubMed ID: 16234521
[TBL] [Abstract][Full Text] [Related]
16. [Hodgkin's disease: treatment of clinical stages II3+A, IB, IIB, IIIA and IIIB with short chemotherapy (3 MOPP, or 3 CVPP), splenectomy and limited irradiation. Results after 4 years of a prospective protocol including 94 patients].
Andrieu JM; Casassus P; Coscas Y; Darmont J; Goubeau C; Katz M; Jacquillat C; Tricot G; Weil M
Bull Cancer; 1982; 69(4):321-9. PubMed ID: 6897520
[No Abstract] [Full Text] [Related]
17. [Chemotherapy of Hodgkin disease with modified MOPP].
Amiel JL; Spielmann M; Kerbrat P; Droz JP; Tursz T; Ben Ayed F
Schweiz Rundsch Med Prax; 1983 Feb; 72(6):190-3. PubMed ID: 6687638
[No Abstract] [Full Text] [Related]
18. [Nitroblue tetrazolium test in Hodgkin's disease (author's transl)].
Hartwich G; Eibl D
Med Klin; 1977 Sep; 72(39):1586-9. PubMed ID: 916943
[TBL] [Abstract][Full Text] [Related]
19. [Drug therapy of Hodgkin's disease].
Gallmeier WM; Bruntsch U
Internist (Berl); 1981 May; 22(5):289-300. PubMed ID: 7019138
[No Abstract] [Full Text] [Related]
20. An elevated serum beta-2-microglobulin level is an adverse prognostic factor for overall survival in patients with early-stage Hodgkin disease.
Chronowski GM; Wilder RB; Tucker SL; Ha CS; Sarris AH; Hagemeister FB; Barista I; Hess MA; Cabanillas F; Cox JD
Cancer; 2002 Dec; 95(12):2534-8. PubMed ID: 12467067
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
